Welcome to LookChem.com Sign In|Join Free
  • or
2-Benzyloxy-6-hydroxynaphthalene is an organic compound with the molecular formula C17H14O2. It is a derivative of naphthalene, a bicyclic aromatic hydrocarbon, and features a hydroxyl group (-OH) at the 6th position and a benzyloxy group (C6H5CH2O) at the 2nd position. 2-benzyloxy-6-hydroxynaphthalene is characterized by its white crystalline appearance and is soluble in organic solvents. It is synthesized through various chemical reactions and is used in the pharmaceutical and chemical industries, particularly as an intermediate in the synthesis of other compounds. Due to its aromatic structure and functional groups, 2-benzyloxy-6-hydroxynaphthalene exhibits unique chemical properties and reactivity, making it a valuable building block in organic synthesis.

2041-17-0

Post Buying Request

2041-17-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2041-17-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 2041-17-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,0,4 and 1 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 2041-17:
(6*2)+(5*0)+(4*4)+(3*1)+(2*1)+(1*7)=40
40 % 10 = 0
So 2041-17-0 is a valid CAS Registry Number.

2041-17-0Relevant academic research and scientific papers

Site-selective Oxidative Dearomatization of Phenols and Naphthols into ortho-Quinols or Epoxy ortho-Quinols using Oxone as the Source of Dimethyldioxirane

Cabrera-Afonso, María J.,Carre?o, M. Carmen,Urbano, Antonio

supporting information, (2019/08/21)

A novel reactivity of dimethyldioxirane, generated in situ from Oxone and acetone, with substituted phenols and naphthols is reported. This methodology allowed the synthesis of ortho-quinols or epoxy ortho-quinols from a site-selective oxidative dearomatization process, with good yields under very mild conditions. A short total synthesis of natural product lacinilene C methyl ether is also described using this process as the key step. (Figure presented.).

Polymerizable compound optical element

-

Paragraph 0182; 0186, (2017/08/26)

PROBLEM TO BE SOLVED: To provide a polymerizable compound which has high solubility with a liquid crystal material and which has little amount of uncured monomers, high stability of a pretilt angle and hardly causes seizure when the compound is added to a liquid crystal material to manufacture a PSA (polymer sustained alignment) display element, and to provide a liquid crystal material containing the polymerizable compound.SOLUTION: The polymerizable compound is expressed by general formula (I). Further, a composition, a liquid crystal composition and an optical element including the compound are also provided.

Imine macrocycle with a deep cavity: Guest-selected formation of syn/anti configuration and guest-controlled reconfiguration

He, Zhenfeng,Ye, Gang,Jiang, Wei

supporting information, p. 3005 - 3012 (2015/02/05)

A dynamic covalent bond is one of the ideal linkages for the construction of large and robust organic architectures. In the present article, we show how organic templates can efficiently transform a complex dynamic imine library into a dynamic imine macrocycle. Not only is the constitution well controlled, but also the syn/anti host configuration is efficiently selected and even the orientation of the guest in the asymmetric cavity of the host can be well aligned. This is attributed to the delicate balance and the cooperation of multiple noncovalent interactions between the hosts and the guests. Through sequential additions of three guests in appropriate amounts, controlled structural reconfiguration of dynamic covalent architectures has been achieved for the first time.

4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists

-

, (2011/05/18)

PCT No. PCT/US96/20872 Sec. 371 Date Sep. 16, 1998 Sec. 102(e) Date Sep. 16, 1998 PCT Filed Dec. 20, 1996 PCT Pub. No. WO97/23216 PCT Pub. Date Jul. 3, 1997Novel 4-substituted piperidine analogs, pharmaceutical compositions containing the same and the method of using 4-substituted piperidine analogs are selective active antagonists of N-methyl-D-aspartate (NMDA) receptor subtypes for treating conditions such as stroke, cerebral ischemia, central nervous system trauma, hypoglycemia, psychosis, anxiety, migraine headaches, glaucoma, CMV retinitis, aminoglycoside antibiotics-induced hearing loss, convulsions, chronic pain, opioid tolerance or withdrawal, urinary incontinence or neurodegenerative disorders, such as lathyrism, Alzheimer's Disease, Parkinsonism and Huntington's Disease are described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 2041-17-0